ArticleFrontiers in oncology2022

B Lymphocytes Are a Predictive Marker of Eribulin Response and Overall Survival in Locally Advanced or Metastatic Breast Cancer: A Multicenter, Two-Cohort, Non-Randomized, Open-Label, Retrospective Study.

Liubov A Tashireva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.